Clinical Trial Update: Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis [Phase 2, Phase 3]

View source ↗

Summary

An update on the efficacy and safety of RPH-104 for recurrent pericarditis across Phase 2 and Phase 3 trials, with the study currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pericarditis

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm Overseas, Inc. | Conditions: Recurrent Pericarditis | Phase 2, Phase 3 | Status: SUSPENDED